Ubs Group Ag Co Diagnostics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 12,773 shares of CODX stock, worth $13,539. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,773

Previous 22,543 43.34%

Holding current value

$13,539

Previous $28,000 46.43%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.02 - $1.75 $9,965 - $17,097	-9,770 Reduced 43.34%	12,773 $15,000
Q2 2024 Aug 13, 2024	BUY	$1.01 - $1.7 $19,848 - $33,408	19,652 Added 679.76%	22,543 $28,000
Q1 2024 May 13, 2024	SELL	$1.06 - $1.42 $6,849 - $9,176	-6,462 Reduced 69.09%	2,891 $3,000
Q4 2023 Feb 09, 2024	BUY	$1.0 - $1.5 $9,253 - $13,879	9,253 Added 9253.0%	9,353 $12,000
Q3 2023 Nov 09, 2023	SELL	$1.03 - $1.85 $1,175 - $2,110	-1,141 Reduced 91.94%	100 $0
Q2 2023 Aug 11, 2023	SELL	$1.04 - $1.64 $4,339 - $6,843	-4,173 Reduced 77.08%	1,241 $1,000
Q1 2023 May 12, 2023	BUY	$1.39 - $3.24 $1,452 - $3,385	1,045 Added 23.92%	5,414 $8,000
Q4 2022 Feb 08, 2023	SELL	$2.32 - $3.68 $9,563 - $15,168	-4,122 Reduced 48.55%	4,369 $11,000
Q3 2022 Nov 10, 2022	BUY	$2.87 - $7.01 $24,369 - $59,521	8,491 New	8,491 $27,000
Q2 2022 Aug 10, 2022	SELL	$3.76 - $6.29 $5,640 - $9,435	-1,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.03 - $9.61 $124,623 - $238,097	-24,776 Reduced 94.29%	1,500 $9,000
Q4 2021 Feb 14, 2022	BUY	$8.12 - $10.37 $77,627 - $99,137	9,560 Added 57.19%	26,276 $235,000
Q3 2021 Nov 15, 2021	SELL	$7.48 - $11.38 $102,924 - $156,588	-13,760 Reduced 45.15%	16,716 $163,000
Q2 2021 Aug 13, 2021	SELL	$7.16 - $9.56 $50,657 - $67,637	-7,075 Reduced 18.84%	30,476 $251,000
Q1 2021 May 12, 2021	BUY	$8.52 - $19.21 $265,466 - $598,545	31,158 Added 487.38%	37,551 $358,000
Q4 2020 Feb 11, 2021	BUY	$9.3 - $15.19 $13,522 - $22,086	1,454 Added 29.44%	6,393 $59,000
Q3 2020 Nov 12, 2020	SELL	$8.24 - $30.8 $146,902 - $549,102	-17,828 Reduced 78.31%	4,939 $67,000
Q2 2020 Jul 31, 2020	BUY	$7.46 - $23.42 $168,126 - $527,816	22,537 Added 9798.7%	22,767 $440,000
Q1 2020 May 01, 2020	BUY	$0.91 - $17.81 $209 - $4,096	230 New	230 $2,000
Q4 2019 Feb 14, 2020	SELL	$0.88 - $1.12 $604 - $769	-687 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$0.81 - $1.35 $5,759 - $9,599	-7,111 Reduced 91.19%	687 $1,000
Q2 2019 Aug 14, 2019	BUY	$0.71 - $1.17 $4,532 - $7,469	6,384 Added 451.49%	7,798 $6,000
Q1 2019 May 14, 2019	SELL	$0.96 - $2.24 $2,967 - $6,923	-3,091 Reduced 68.61%	1,414 $2,000
Q4 2018 Feb 14, 2019	BUY	$1.15 - $2.61 $1,730 - $3,928	1,505 Added 50.17%	4,505 $7,000
Q3 2018 Nov 14, 2018	BUY	$2.63 - $4.24 $2,082 - $3,358	792 Added 35.87%	3,000 $8,000
Q2 2018 Aug 14, 2018	SELL	$1.62 - $5.28 $4,302 - $14,023	-2,656 Reduced 54.61%	2,208 $9,000
Q1 2018 May 15, 2018	BUY	$1.56 - $3.2 $6,126 - $12,566	3,927 Added 419.1%	4,864 $11,000
Q4 2017 Feb 14, 2018	BUY	$2.38 - $6.72 $2,230 - $6,296	937	937 $2,000

Others Institutions Holding CODX

# of Institutions

Shares Held

4.3M

Call Options Held

48.2K

Put Options Held

53.3K

View Full List

About Co-Diagnostics, Inc.

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

More about CODX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account